Skip to main content

ADVERTISEMENT

peripheral artery disease

Review
07/15/2021

Jihad A. Mustapha, MD1;  Fadi A. Saab, MD1;  Brad J. Martinsen, PhD2;  Ann N. Behrens, BS2;  Miguel F. Montero-Baker, MD3;  Bret N. Wiechmann, MD4;  Eric C. Scott, MD5;  David G. Armstrong, DPM, MD, PhD6;  Nicolas W. Shammas, MD7;  George L. Adams, MD8

Jihad A. Mustapha, MD1;  Fadi A. Saab...
We review here the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
We review here the mechanism of action of OA, supporting clinical study evidence, and corresponding economic analyses.
We review here the mechanism of...
07/15/2021
CardioVascular
Original Contribution
06/08/2021

Antonio Micari, MD, PhD1;  Jeffrey J. Popma, MD2;  Francesco Liistro, MD3 

Antonio Micari, MD, PhD1;  Jeffrey J....
This is a pilot feasibility study and the objective is to evaluate the safety and effectiveness of the investigational device, IN.PACT 014 drug-coated balloon, compared with standard PTA in patients with CLI with CTOs of BTK arteries. 
This is a pilot feasibility study and the objective is to evaluate the safety and effectiveness of the investigational device, IN.PACT 014 drug-coated balloon, compared with standard PTA in patients with CLI with CTOs of BTK arteries. 
This is a pilot feasibility...
06/08/2021
Cath Lab Digest
Original Contribution
09/30/2017

Zoltan Ruzsa, MD, PhD1,2;  Joanna Wojtasik-Bakalarz, MD3;  Andras Nyerges, MD2;  Tomasz Rakowski, MD, PhD3; Pawel Kleczynski, MD, PhD3;  Stanislaw Bartus, MD, PhD3

Zoltan Ruzsa, MD, PhD1,2;  Joanna Woj...
CTO of the SFA occurs in >50% of the patient population with peripheral artery disease. This study assesses the safety of the retrograde procedure with long-term follow-up of 86 patients; our results show a high technical success rate and...
CTO of the SFA occurs in >50% of the patient population with peripheral artery disease. This study assesses the safety of the retrograde procedure with long-term follow-up of 86 patients; our results show a high technical success rate and...
CTO of the SFA occurs in >50%...
09/30/2017
Journal of Invasive Cardiology
Original Contribution
08/29/2017

Shwan Jalal, MD1;  Jihad A. Mustapha, MD2;  Howard S. Rosman, MD1;  Rajendra H. Mehta, MD, MS3;  Thomas P. Davis, MD1

Shwan Jalal, MD1;  Jihad A. Mustapha,...
Appropriate use criteria (AUC) for coronary revascularization were developed to deliver high-quality care; however, the prognostic impact of these criteria remains unclear. We sought to assess the outcomes of patients treated with...
Appropriate use criteria (AUC) for coronary revascularization were developed to deliver high-quality care; however, the prognostic impact of these criteria remains unclear. We sought to assess the outcomes of patients treated with...
Appropriate use criteria (AUC)...
08/29/2017
Journal of Invasive Cardiology
Original Contribution
12/31/2016

Junya Matsumi, MD;  Takuma Takada, MD;  Noriaki Moriyama, MD;  Tomoki Ochiai, MD;  Kazuki Tobita, MD; Koki Shishido, MD;  Kazuya Sugitatsu, MD;  Shingo Mizuno, MD;  Futoshi Yamanaka, MD;  Masato Murakami, MD;  Yutaka Tanaka, MD;  Saeko Takahashi;  Takeshi Akasaka, MD;  Shigeru Saito, MD

Junya Matsumi, MD;  Takuma Takada, MD...
This study evaluated long-term results following successful endovascular therapy for chronic total occlusion below the knee using the retrograde approach after a failed antegrade approach.
This study evaluated long-term results following successful endovascular therapy for chronic total occlusion below the knee using the retrograde approach after a failed antegrade approach.
This study evaluated long-term...
12/31/2016
Journal of Invasive Cardiology